A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Pfizer
Pfizer
Pfizer
Regeneron Pharmaceuticals
Novartis
Merck Sharp & Dohme LLC
DEKA Biosciences
Regeneron Pharmaceuticals
Tempus AI
Alpha Tau Medical LTD.
Barco NV
Checkpoint Therapeutics, Inc.